"As your partner in health, we’re dedicated to making it easier for you to live well—so you can show up for the moments that matter most. To us, people are more than patients. We work together as a team to champion high-quality, low-cost care. Our providers and services span hospitals, clinics and at home settings across Iowa, Illinois and Wisconsin. Our presence in metropolitan and rural communities allows us to innovate through partnerships, organizations outside of healthcare, and our family of team members remains dedicated to shared values that put our people first. Because you matter to this world, and we’ll show you just how much."

During the past decade, Blank Children's Hospital conducted 62 clinical trials. In the 10-year time frame, 62 clinical trials started and 55 clinical trials were completed, i.e. on average, 88.7% percent of trials that started reached the finish line to date. In the past 5 years, 21 clinical trials started and 31 clinical trials were completed. i.e. 147.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Blank Children's Hospital" #1 sponsor was "Children's Oncology Group" with 90 trials, followed by "National Cancer Institute (NCI)" with 48 trials sponsored, "Bristol-Myers Squibb" with 2 trials sponsored, "Sucampo Pharma Americas, LLC" with 2 trials sponsored and "University of Iowa" with 2 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 13 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Blank Children's Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 90 trials as a collaborator, "Children's Oncology Group" with 6 trials as a collaborator, "Pfizer" with 3 trials as a collaborator, "Blank Children's Hospital" with 2 trials as a collaborator and "American Academy of Pediatrics" with 1 trials as a collaborator. Other collaborators include 10 different institutions and companies that were collaborators in the rest 20 trials.

According to Clinical.Site data, the most researched conditions in "Blank Children's Hospital" are "Recurrent Neuroblastoma" (19 trials), "Refractory Neuroblastoma" (15 trials), "Refractory Non-Hodgkin Lymphoma" (14 trials), "Recurrent Hepatoblastoma" (13 trials) and "Recurrent Malignant Solid Neoplasm" (13 trials). Many other conditions were trialed in "Blank Children's Hospital" in a lesser frequency.

Most popular intervention types in "Blank Children's Hospital" are "Drug" (115 trials), "Other" (84 trials), "Procedure" (51 trials), "Biological" (46 trials) and "Radiation" (40 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (51 trials), "Cyclophosphamide" (36 trials), "Vincristine Sulfate" (33 trials), "Doxorubicin Hydrochloride" (25 trials) and "Etoposide" (25 trials). Other intervention names were less common.

The vast majority of trials in "Blank Children's Hospital" are 150 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Blank Children's Hospital". undefined are not yet recruiting, 30 are recruiting, 52 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 66 completed trials in Blank Children's Hospital, 3 suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Blank Children's Hospital, 5 "Phase 1" clinical trials were conducted, 53 "Phase 2" clinical trials and 62 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 8 trials that are defined as “Not Applicable".